Literature DB >> 12664011

Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathology.

Knut Brockow1, Cem Akin, Mary Huber, Dean D Metcalfe.   

Abstract

BACKGROUND: Cutaneous involvement occurs in most patients with systemic mastocytosis.
OBJECTIVE: We sought to determine whether the extent of cutaneous involvement is predictive of systemic disease.
METHODS: In a prospective survey of 48 adults and 19 children, the extent and density of cutaneous lesions were compared with patient history, symptoms, internal organ involvement, serum total mast cell tryptase level, and bone marrow pathology.
RESULTS: Cutaneous lesions in children were of a greater mean and maximum diameter, but similar in extent and density compared with lesions in adults. In adults with skin lesions, the extent of lesions correlated to disease duration. Adults with extensive cutaneous disease experienced more pruritus and flushing. Fatigue, splenomegaly, and hepatomegaly were more frequent in adults without cutaneous involvement; and in those with a greater density of lesions and disease duration. Increased tryptase levels were found in children and adults with systemic disease and correlated to skin lesion density and bone marrow pathology.
CONCLUSION: An examination of the extent and density of cutaneous lesions in adults helps identify those with more extensive extracutaneous disease and, thus, requiring a more thorough evaluation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12664011     DOI: 10.1067/mjd.2003.98

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  19 in total

1.  Systemic mastocytosis: predominantly involving the bone, a case report.

Authors:  Ketan P Mallya; Sushma Belurkar; Annamma Kurian; Laxmi Rao; Bikash Singhania
Journal:  J Clin Diagn Res       Date:  2013-10-05

2.  Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis.

Authors:  Melody C Carter; Sarah T Clayton; Hirsh D Komarow; Erica H Brittain; Linda M Scott; Daly Cantave; Donna M Gaskins; Irina Maric; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2015-06-01       Impact factor: 10.793

Review 3.  Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations.

Authors:  Mariana Castells; Dean D Metcalfe; Luis Escribano
Journal:  Am J Clin Dermatol       Date:  2011-08-01       Impact factor: 7.403

Review 4.  Cutaneous and systemic mastocytosis in children: a risk factor for anaphylaxis?

Authors:  A Matito; M Carter
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

Review 5.  Primary mast cell disorders in children.

Authors:  Ari J Fried; Cem Akin
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

6.  Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis.

Authors:  I Alvarez-Twose; S Vañó-Galván; L Sánchez-Muñoz; J M Morgado; A Matito; A Torrelo; P Jaén; L B Schwartz; A Orfao; L Escribano
Journal:  Allergy       Date:  2012-03-28       Impact factor: 13.146

Review 7.  Mastocytosis.

Authors:  Knut Brockow; Dean D Metcalfe
Journal:  Chem Immunol Allergy       Date:  2010-06-01

Review 8.  Mastocytosis.

Authors:  Melody C Carter; Dean D Metcalfe; Hirsh D Komarow
Journal:  Immunol Allergy Clin North Am       Date:  2013-10-07       Impact factor: 3.479

9.  Regulation of normal and neoplastic human mast cell development in mastocytosis.

Authors:  Dean D Metcalfe
Journal:  Trans Am Clin Climatol Assoc       Date:  2005

Review 10.  Pediatric Mastocytosis: Recognition and Management.

Authors:  Julie V Schaffer
Journal:  Am J Clin Dermatol       Date:  2021-03       Impact factor: 7.403

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.